Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVBI Vaccines Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
VBI Vaccines Inc Earnings Date And Information
VBI Vaccines Inc last posted its earnings results on Monday, August 12th, 2024. The company reported $-2.17 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $1.85. The company had revenue of 1.21 M for the quarter and had revenue of 8.68 M for the year. VBI Vaccines Inc has generated $-6 earnings per share over the last year ($-5.96 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. VBI Vaccines Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
VBI Vaccines Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2024 | Q1 2024 | -$0.53 | -$0.73 | -0.2 | $2.85 M | $1.21 M |
| 04/16/2024 | Q4 2023 | N/A | -$0.00 | N/A | $5.36 M | $853.00 K |
| 11/14/2023 | Q3 2023 | -$0.14 | -$0.97 | -0.83 | $13.25 M | $6.62 M |
| 08/14/2023 | Q2 2023 | -$2.16 | -$5.18 | -3.02 | $929.00 K | $720.00 K |
| 05/15/2023 | Q1 2023 | -$2.27 | -$4.34 | -2.07 | $817.00 K | $485.00 K |
| 03/13/2023 | Q4 2022 | -$2.10 | -$2.28 | -0.18 | $1.98 M | $293.00 K |
| 11/10/2022 | Q3 2022 | -$2.40 | -$3.26 | -0.86 | $1.29 M | $317.00 K |
| 08/08/2022 | Q2 2022 | -$2.10 | -$7.85 | -5.75 | $704.33 K | $346.00 K |
| 05/09/2022 | Q1 2022 | -$2.40 | -$2.98 | -0.58 | $120.00 K | $126.00 K |
| 03/07/2022 | Q4 2021 | -$2.10 | -$2.19 | -0.09 | $137.33 K | $81.00 K |
| 11/08/2021 | Q3 2021 | -$2.40 | -$1.85 | 0.55 | $203.67 K | $107.00 K |
| 08/02/2021 | Q2 2021 | -$2.40 | -$2.05 | 0.35 | $481.33 K | $142.00 K |
| 05/10/2021 | Q1 2021 | -$2.10 | -$2.11 | -0.01 | $485.00 K | $301.00 K |
| 03/02/2021 | Q4 2020 | -$1.80 | -$1.90 | -0.1 | $407.00 K | $164.00 K |
| 11/02/2020 | Q3 2020 | -$1.50 | -$1.66 | -0.16 | $328.25 K | $298.00 K |
| 07/31/2020 | Q2 2020 | -$1.50 | -$1.32 | 0.18 | $631.25 K | $184.00 K |
| 05/06/2020 | Q1 2020 | -$2.10 | -$1.41 | 0.69 | $655.25 K | $415.00 K |
| 03/05/2020 | Q4 2019 | -$1.80 | -$1.82 | -0.02 | $729.75 K | $574.00 K |
| 11/06/2019 | Q3 2019 | -$3.60 | -$4.59 | -0.99 | $702.67 K | $647.00 K |
| 08/09/2019 | Q2 2019 | -$4.20 | -$4.04 | 0.16 | $489.00 K | $640.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VBI Vaccines Inc Earnings: FAQ's
The conference call for VBI Vaccines Inc's latest earnings report can be listened to online.
The conference call transcript for VBI Vaccines Inc's latest earnings report can be read online.
VBI Vaccines Inc (:VBIV) has a recorded annual revenue of $8.68 M.
VBI Vaccines Inc (:VBIV) has a recorded net income of $-92,836,000.VBI Vaccines Inc has generated $-5.96 earnings per share over the last four quarters.
VBI Vaccines Inc (:VBIV) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.